1.
Wang L-S,
Chuang M-C,
Ho J-AA.
Nanotheranostics-a review of recent publications.
Int J Nanomedicine 2012; 7: 4679–95.
2.
Echevarria JJ,
García-Alonso I,
Díaz I,
Herrero B,
Miguélez JL,
Zabalza I,
et al.
Ultrasonographic characterization of an experimental model of liver metastases from colon carcinoma in rats.
Radiología.
2010; 52 (1): 37-44.
doi:10.1016/j.rx.2009.09.010
3.
Hutteman M,
Mieog JSD,
Van der Vorst JR,
Dijkstra J,
Kuppen PJK,
Van der Laan AMA,
et al.
Intraoperative near-infrared fluorescente imaging of colorectal metastases targeting integrin alfaVbeta3 expression in a syngeneic rat model.
EJSO 2011; 37:252-7.
4.
Yun W,
Weibo C,
Xiaoyuan C.
Near-infrared fluorescence imaging of tumor integrin αVβ3 expression with Cy7-labeled RGD multimers.
Mol Imaging Biol 2006; 8(4):226-36.
5.
Aizpurua JM,
Ganboa JI,
Palomo C,
Loinaz I,
Oyarbide J,
Fernandez X,
et al.
Cyclic RGD beta-lactam peptidomimetics induce differential gene expression in human endothelial cells.
Chembiochem 2011; 12(3):401-5.
6.
Aizpurua JM,
Azcune I,
Fratila RM,
Balentova E,
Sagartzazu-Aizpurua M,
Miranda JI.
"Click" synthesis of nonsymmetrical bis(1,2,3-triazoles).
Org Lett 2010; 12(7):1584-7.
7.
Kossodo S,
Pickarski M,
Lin S-A et al.
Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT).
Mol Imaging Biol 2010;12(5):488-99.
8.
Lee HY,
Li Z.
Chen K,
Hsu AR,
Xu C,
Xie J,
et al.
PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
J Nucl Med 2008; 49(8):1371-9.
9.
Xie J,
Chen K,
Lee HY,
Xu C,
Hsu AR,
Peng S,
et al.
Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells.
J Am Chem Soc 2008;130(24):7542-3.
